← Leaderboards
Matthew Everett Griffin
University Of California-Irvine
$1,711,019
Attributed
$1,711,019
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$1,711,019 · 2
By mechanism
DP2$1,227,751 · 1
K22$483,268 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Michael Demetriou$19,395,048
- Manuela Raffatellu$10,626,800
- Natalie Falco$91,956
- Ashlee Miriam Earl$16,638,111
- Erlinda Rose Ulloa$1,026,191
Others in their field
Other Rising Stars on “Polysaccharides”
- John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc.$6,183,017
- Jeff T Hutchins · Inhalon Biopharma, Inc.$5,672,575
- Zhangjie Wang · Glycan Therapeutics Corporation$4,315,125
- Magnus Adrian Gero Hoffmann · California Institute Of Technology$3,559,750
- Sean Michael Gibbons · Institute For Systems Biology$3,006,256
- Jacob Matthew Allen · University Of Illinois At Urbana-Champaign$2,622,833
Research focus
PolysaccharidesMediatingMolecularProbioticsImmunityImmuneMalignant NeoplasmsMicrobialSignal TransductionTissuesMicrobeBiochemicalAffinityBiological ModelsBacteriaAntigensCell WallCheckpoint TherapyCancer TypeCd47 GeneCancer TherapyApplications GrantsCareerCancer Patient
Grant awards (4)
Chemical glycobiology tools to decipher host-microbiota interactions$1,227,751
DP2 · FY2025 · AT · contact PI
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites$142,625
K22 · FY2025 · CA · contact PI
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites$142,625
K22 · FY2024 · CA · contact PI
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites$198,018
K22 · FY2023 · CA · contact PI